Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution-Reference-Cited by-同舟云学术

Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution

Published:2012-01-17 Issue:4 Volume:5 Page:1043-1048
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:en
Short-container-title:

Author:

CHEN PO-YUAN,TSAI CHING-TSAN,OU CHE-YEN,HSU WEI-TSE,JHUO MIEN-DE,WU CHIEH-HSI,SHIH TZU-CHING,CHENG TZU-HURNG,CHUNG JING-GUNG

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel dual acetylcholinesterase and butyrylcholinesterase inhibitors using machine learning and structure-based drug design;Journal of Molecular Structure;2023-08

2. Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a);Journal of Biomolecular Structure and Dynamics;2023-05-22

3. Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors;Molecular Diversity;2022-10-10

4. Structure-guided pharmacophore based virtual screening, docking, and molecular dynamics to discover repurposed drugs as novel inhibitors against endoribonuclease Nsp15 of SARS-CoV-2;Journal of Biomolecular Structure and Dynamics;2022-06-02

5. Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review;Current Neuropharmacology;2021-11